2026-01-28 - Analysis Report
**Stock Analysis Report: Amphenol (APH)**

### Overview
Amphenol is a global designer, manufacturer, and marketer of electrical, electronic and fiber-optic connectors, interconnect systems, and related products.

### Return Rate Comparison
**Cumulative Return**
- Review stock (APH): **516.60%**
- Comparison stock (S&P 500, VOO): **128.51%**
- Divergence (max: 349.40, min: -15.70, current: 349.40, relative divergence: 100.00%)

### Alpha and Beta Analysis
| **Year** | **CAGR** | **MDD** | **Alpha** | **Beta** | **Cap ($B)** |
| --- | --- | --- | --- | --- | --- |
| **2016-2018** | 13.0% | 16.0% | 4.0% | 0.9 | 24.8 |
| **2017-2019** | 27.0% | 16.7% | 2.0% | 1.1 | 33.1 |
| **2018-2020** | 23.0% | 35.5% | -1.0% | 1.0 | 40.0 |
| **2019-2021** | 80.0% | 35.5% | 16.0% | 1.1 | 53.5 |
| **2020-2022** | 36.0% | 33.5% | 32.0% | 1.1 | 46.6 |
| **2021-2023** | 51.0% | 25.0% | 33.0% | 1.1 | 60.7 |
| **2022-2024** | 91.0% | 19.3% | 62.0% | 1.1 | 85.0 |
| **2023-2025** | 327.0% | 23.7% | 251.0% | 1.3 | 165.4 |

### Recent Stock Price Fluctuations
- Close: **$166.25**
- Last-market: {'price': 166.25, 'previousClose': 155.56, 'change': 6.87}
- 5-day SMA: **$155.98**
- 20-day SMA: **$146.31**
- 60-day SMA: **$139.96**

### RSI and PPO Index Indicators
- Market Risk Indicator (MRI): **0.70** (0.9~1.0: High Investment Recommended, 0.7~0.9: Medium Investment, 0.4~0.7: Low Investment, <0.4: Very Risky)
- RSI: **74.43**
- PPO: **0.98**
- Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.70)
- Recent (20 days) relative divergence change: **0.00** (0): flat
- 7-day Rank change: **5 (+)**: rank up
- 7-day Dynamic Expected Return change: **11.10 (+)**: improving
Expected Return (%): **12.70%**, Expected excess return compared to S&P 500 if invested long-term (more than 2 years) from this point.

### Recent News & Significant Events
[Bull of the Day: Amphenol (APH) - Zacks Investment Research](link)  
[JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Amphenol (NYSE:APH) Stock - MarketBeat](link)  
[JP Morgan Raises Amphenol (APH) Price Target to $185, Maintains Overweight Rating | APH Stock News - GuruFocus](link)  
[Amphenol Corp. (NYSE:APH) Presents a High-Growth Momentum and Technical Breakout Opportunity - Chartmill](link)  
[Fund Update: 170,668 AMPHENOL (APH) shares added to WHITTIER TRUST CO portfolio - Quiver Quantitative](link)  
[Hereâ€™s What Wall Street Thinks About Amphenol Corporation (APH) - Yahoo Finance](link)

### Analyst Opinions
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): **1.78 (~Buy)**
- Opinions: **18**
- Target Price (avg/high/low): **160.49 / 200.00 / 115.00**

### Recent Earnings Analysis
| **Date** | **EPS** | **Revenue** |
| --- | --- | --- |
| 2025-10-24 | **1.02** | **$6.19B** |
| 2025-07-25 | **0.9** | **$5.65B** |
| 2025-04-25 | **0.61** | **$4.81B** |
| 2024-10-25 | **0.5** | **$4.04B** |
| 2025-10-24 | **0.5** | **$4.04B** |

**Revenue and Profitability**
| **Quarter** | **Revenue** | **Profit Margin** |
| --- | --- | --- |
| 2025-09-30 | **$6.19B** | **38.09%** |
| 2025-06-30 | **$5.65B** | **36.34%** |
| 2025-03-31 | **$4.81B** | **34.17%** |
| 2024-12-31 | **$4.32B** | **34.29%** |
| 2024-09-30 | **$4.04B** | **33.60%** |

**Capital and Profitability**
| **Quarter** | **Equity** | **ROE** |
| --- | --- | --- |
| 2025-09-30 | **$12.52B** | **9.95%** |
| 2025-06-30 | **$11.52B** | **9.47%** |
| 2025-03-31 | **$10.30B** | **7.16%** |
| 2024-12-31 | **$9.79B** | **7.62%** |
| 2024-09-30 | **$9.45B** | **6.39%** |

### Comprehensive Analysis (Summary of previous items)
Amphenol (APH) has shown remarkable growth over the past five years, with a cumulative return of **516.60%** compared to the S&P 500's **128.51%**. The company's alpha and beta analysis indicates a high growth potential with a low risk profile. The recent stock price fluctuations show a sharp rebound, with a 5-day SMA of **$155.98**, 20-day SMA of **$146.31**, and 60-day SMA of **$139.96**. The RSI and PPO index indicators suggest a medium risk level, with a Market Risk Indicator (MRI) of **0.70**. The analyst opinions are overwhelmingly in favor of the stock, with a mean opinion of **1.78**, suggesting a "Buy" rating. The recent earnings analysis shows a consistent revenue growth trend, with a current estimate of **$6.19B**. Overall, Amphenol appears to be a highly attractive investment opportunity with a strong growth potential and a low risk profile.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.